Skip to content

Insider · CIK 0002014440

Woodrow D Anderson

officer

Files at INDV (Indivior Pharmaceuticals, Inc.). First filing -, latest -.

Woodrow D Anderson files SEC Form 4 as officer at INDV (Indivior Pharmaceuticals, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.

A track record needs three past buys with six months of prices behind them; Woodrow D Anderson has 0, so none is measured yet.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

No scored open-market trades yet.

Transactions

Every row this insider has filed, 8 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Mar 3, 2026INDV
Indivior Pharmaceuticals, Inc.
MOption exercise
Common Stock
+18,364--29,657Mar 5, 2026
Mar 3, 2026INDV
Indivior Pharmaceuticals, Inc.
FTax withholding
Common Stock
-8,283$31.98$265k21,374Mar 5, 2026
Mar 3, 2026INDV
Indivior Pharmaceuticals, Inc.
MOption exercise
Common Stock
+5,946--27,320Mar 5, 2026
Mar 3, 2026INDV
Indivior Pharmaceuticals, Inc.
FTax withholding
Common Stock
-2,682$31.98$86k24,638Mar 5, 2026
Mar 3, 2026INDV
Indivior Pharmaceuticals, Inc.
MOption exercise
Performance Stock Unitsderivative
-23,975--0Mar 5, 2026
Mar 3, 2026INDV
Indivior Pharmaceuticals, Inc.
MOption exercise
Restricted Stock Unitsderivative
-5,946--0Mar 5, 2026
Feb 10, 2026INDV
Indivior Pharmaceuticals, Inc.
AGrant or award
Common Stock
+6,903$0.00$011,293Feb 12, 2026
Feb 9, 2026INDV
Indivior Pharmaceuticals, Inc.
AGrant or award
Performance Stock Unitsderivative
+23,975$0.00$023,975Feb 12, 2026

Questions about Woodrow D Anderson

Answered from the filings on this page, as of the latest one.

Is Woodrow D Anderson buying or selling?

Woodrow D Anderson has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.

How did Woodrow D Anderson's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Woodrow D Anderson has 0.

Where does Woodrow D Anderson file Form 4?

Woodrow D Anderson has filed Form 4 at INDV (Indivior Pharmaceuticals, Inc.) as Chief Accounting Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Woodrow D Anderson: insider trades and track record | InsiderTell